Business Context and Reporting Period
This Form 6-K filing by GSK plc (GSK) reports a transaction in the company's own shares. The filing date is August 21, 2025, covering a share repurchase executed on August 20, 2025. The transaction was conducted through Merrill Lynch International as part of an existing buyback programme established via a non-discretionary agreement on June 4, 2025.
Key Financial Metrics
The filing details a specific share repurchase event rather than comprehensive financial results. Key metrics for the transaction on August 20, 2025, include:
- Shares Purchased: 214,694 ordinary shares.
- Price Range: Lowest price paid was 1,450.50 GBp; highest price paid was 1,491.50 GBp.
- Volume-Weighted Average Price (VWAP): 1,476.50 GBp.
- Trading Venue: All purchases occurred on the London Stock Exchange (XLON).
- Treasury Shares: Following this purchase, GSK holds 242,924,721 ordinary shares in treasury.
- Shares in Issue: 4,072,467,013 ordinary shares (excluding treasury shares).
- Treasury Voting Rights: 5.97% of total voting rights.
Revenue, profit, cash flow, margins, and debt figures are not provided in this specific filing.
Material Changes
Since the commencement of the buyback programme on June 4, 2025, GSK has purchased an aggregate of 24,790,338 ordinary shares. The August 20 transaction represents a continuation of this programme. There are no other material changes to the company's financial position or operations disclosed in this document.
Guidance, Outlook, and Risks
The filing contains no new guidance or outlook regarding future financial performance. It includes a standard cautionary statement noting that forward-looking statements are subject to risks and uncertainties. Investors are directed to the "Risk Factors" section of GSK's Annual Report on Form 20-F for 2024 and the Q2 Results for 2025 for a detailed description of these risks.
Important Facts for Investors
- Verify the total number of shares in issue (4,072,467,013) when calculating ownership percentages for disclosure thresholds under FCA rules.
- Note that treasury shares (242,924,721) represent 5.97% of voting rights and do not carry voting rights.
- Confirm that the buyback is being executed under a non-discretionary agreement with Merrill Lynch International.
- Review the full list of individual trades in the schedule to understand the execution price distribution, which ranged from 1,450.50p to 1,491.50p.